While the search for germ-line variants in BRCA1 have predominantly focused on open-reading-frame variants, increasing evidence is showing that alterations in non-coding regions of genes (such as this variant) explain a proportion of cancer susceptibility, and more importantly play a role in tumor biology and can act as prognostic biomarkers. This evidence concerns the gene BRCA1 and neoplasm.